(Q37581591)

21 August 2017

1 reference

title

Armodafinil. (English)

1 reference

21 August 2017

1 reference

ChEBI release 2020-05-28

1

Karly P Garnock-Jones

1 reference

21 August 2017

3

Lesley J Scott

1 reference

21 August 2017

2

Sohita Dhillon

1 reference

21 August 2017

publication date

1 September 2009

1 reference

21 August 2017

1 reference

21 August 2017

volume

23

1 reference

21 August 2017

issue

9

1 reference

21 August 2017

page(s)

793-803

1 reference

https://scigraph.springernature.com/pub.10.2165/11203290-000000000-00000

21 August 2017

exact match

0 references

cites work

Modafinil: preclinical, clinical, and post-marketing surveillance--a review of abuse liability issues.

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F11203290-000000000-00000

Managing excessive daytime sleepiness in adults

21 January 2018

1 reference

12 December 2020

Clinical pharmacokinetic profile of modafinil

1 reference

12 December 2020

Pharmacodynamic effects on alertness of single doses of armodafinil in healthy subjects during a nocturnal period of acute sleep loss

1 reference

12 December 2020

The efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsy.

1 reference

12 December 2020

A double-blind, placebo-controlled, ascending-dose evaluation of the pharmacokinetics and tolerability of modafinil tablets in healthy male volunteers.

1 reference

12 December 2020

Modafinil : a review of its use in excessive sleepiness associated with obstructive sleep apnoea/hypopnoea syndrome and shift work sleep disorder

1 reference

12 December 2020

Pharmacokinetic profile of armodafinil in healthy subjects: pooled analysis of data from three randomized studies

1 reference

12 December 2020

Interaction profile of armodafinil with medications metabolized by cytochrome P450 enzymes 1A2, 3A4 and 2C19 in healthy subjects

1 reference

12 December 2020

Armodafinil for excessive daytime sleepiness

1 reference

12 December 2020

Open-label, single-dose pharmacokinetic study of modafinil tablets: influence of age and gender in normal subjects.

1 reference

12 December 2020

Management of shift work sleep disorder: Alice in Wonderland redux?

1 reference

12 December 2020

Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults.

1 reference

12 December 2020

Adjunct armodafinil improves wakefulness and memory in obstructive sleep apnea/hypopnea syndrome.

1 reference

12 December 2020

Armodafinil promotes wakefulness and activates Fos in rat brain

1 reference

12 December 2020

10.2165/11203290-000000000-00000

Identifiers

DOI

1 reference

Dimensions Publication ID

21 August 2017

1028016240

0 references

1 reference